Background. The renal arterial resistance index (RI) is reported to be a significant predictive parameter for renal allograft failure or death. The influence of the time point after renal transplantation on its predictive power has not been sufficiently evaluated. We performed a retrospective analysis of RI and its power to predict renal allograft failure or death with special emphasis on the time point of RI measurement.
Introduction
The prognosis for both patient and organ survival after renal transplantation has increased substantially within the last decades [1] . In the year 2007, renal transplantation in the USA led to 91% allograft survival within the first year and in living kidney transplants 97% [2] . For the monitoring of renal allograft recipients and early detection of graft failure, physicians have been seeking an easily accessible tool combining satisfactory sensitivity and specificity.
In the landmark prospective trial by Radermacher et al. [3] , an ultrasonographic arterial resistance index (RI) of a transplant kidney >0.80 was identified as a powerful predictor of reaching a combined end point after renal transplantation (i.e. a decrease of creatinine clearance of ≥50%, need for dialysis or patient death). In a multivariate analysis, a renal RI >0.80 was associated with a higher relative risk of reaching this combined end point than proteinuria >1 g/day, symptomatic cytomegalovirus infection and others [3] . The authors concluded that none of the various traditional risk factors for poor post-transplant outcome included in their study approached the predictive value of an RI >0.80 [3] . However, despite its power, this study suffers from one major limitation in study design. The time frame in which the RI measurements were performed included markedly variable points of time after renal transplantation: median 40 months and range 3-317 months [3] . Based on our clinical experience, we hypothesized that a renal RI obtained early after renal transplantation may be less suitable to predict outcome than later RI measurements since we experienced substantial intra-individual fluctuations in the RI early after transplantation.
We therefore performed a retrospective single-centre analysis of RI measurements and their power to predict renal allograft survival with special regard to the time point of RI measurement. We hypothesized that the RI's prognostic power varies with the time interval from renal transplantation.
Materials and methods
The present analysis is based on ultrasonographically recorded intrarenal arterial RIs, which were all prospectively recorded in the transplant unit outpatient department of the Aachen University Hospital in a time period of 13 years. Altogether, 396 patients [222 (56%) men] with 5717 scans were recorded. Only 88 (22%) of these patients [52 (59%) men] who had at least one RI measurement in three predefined time periods (0-3, 3-6 and 12-18 months) after transplantation were included into the study. Only the first RI value measured in the time period was included (0-3 months: median 8 days, range 1-46/mean 10.8, SD 7.9; 3-6 months: median 92 days, range 92-181/mean 121.6, SD 26.8 and 12-18 months: median 417 days, range 367-546/mean 427.4, SD 48.2). We chose these three time periods to verify our hypothesis that an RI measured early after transplantation (days to weeks) is, due to many influencing factors, less capable of predicting allograft survival than the RI obtained later (months after transplantation). Therefore, we included both outpatient as well as in-hospital patients early after transplantation in the first time period of RI measurements. The third time period was selected due to our clinical experience that the renal arterial RI varies in the first months after transplantation and then swings into a stable steady state 9-12 months after transplantation.
One (1.1%) patient had received three and two patients (2.3%) had received two kidney transplantations. At the time of transplantation, the mean age of the patients was 44 years (SD 12, minimum 10 years, maximum 68 years). All 88 patients received their renal allograft in Aachen. The patients were retrospectively stratified into two groups according to the RI for their transplant: those with an RI >0.75 and those with an RI of ≤0.75. The combined end point was terminal transplant failure requiring the re-institution of chronic dialysis or death from any cause.
Ultrasonographic examination for RI measurement
Ultrasonographic examination was performed using two different machines: (i) Sonoline (Siemens, Erlangen-Nürnberg) with a 3.5-MHz Sectorscanner and (ii) by Sonolayer SSA 270A (Toshiba 3.75 MHz). Altogether, 18 investigators were involved in RI measurements, which were all supervised by a single instructor who performed 48% of all ultrasound examinations himself. Intrarenal Doppler signals were received from three proximal segmental arteries. The peak systolic velocity (V max ) and the minimal diastolic velocity (V min ) were determined, the renal segmental arterial RI was calculated as 100 × [1 − (V min /V max )] and the results from three measurements were averaged.
Statistical analysis
Continuous data are reported as means and corresponding SDs. Categorical data are presented by frequencies and percentages. A receiver operating characteristics (ROC) analysis was performed to determine a cut-off RI. For the resulting cut-off and the cut-off 0.75, sensitivity, specificity and predictive values were calculated. Baseline characteristics were compared according to the cut-off by means of t-test or Fisher's exact test, respectively.
For model building, we studied all exploratory factors in a univariate Cox proportional hazard regression model. The following factors were investigated: RI (0-3, 3-6 and 12-18 months); cold ischaemia time; serum creatinine >1.2 mg/dL and glomerular filtration rate calculated by the formula of Cockcroft and Gault (early = discharge from the hospital, 1 year, 2 years); whether the graft was from a living or cadaveric donor; age of the patient; age of the donor; sex of the patient; cytomegalovirus risk; whether the donor or the recipient was cytomegalovirus positive; mean systolic and diastolic blood pressure and pulse pressure; solution used for perfusion (Euro-Collins versus Histidine-Tryptophan-Ketoglutarate or University of Wisconsin); number of mismatches at the HLA-A, -B and -DR loci; presence of cytotoxic antibodies; time on dialysis; number of anti-hypertensive drugs used; body mass index and occurrence of post-transplant acute kidney injury i.e. need for dialysis within 7 days after transplantation ( post-Tx AKI), presence or absence of hypertension in the diagnoses list of the discharge note, occurrence of a treated rejection and number of renal transplantations. In regard to the RI, only the first one measured within the time period was included into the study. Data about the medical history, medications and transplantrelated data were obtained by retrospective chart review or analysis of databases provided by Eurotransplant. Factors were assessed as relevant to be included in the final multivariate logistic regression model with stepwise selection if the P-value was <0.25. The resulting model was designed to discover those factors contributing significant information (P-value falls below the 5% margin) for predicting renal allograft failure or death. All test results are reported as hazard ratios (HRs), corresponding 95% limits of confidence (95% CI) and P-values.
All analyses were done using SAS® statistical software, V9.2 (SAS Institute, Cary, NC) under Windows XP.
Interobserver variability (additional prospective study)
Due to the large number of sonographers (n = 18) in our study, the interobserver variability of ultrasonographic RI determination is a potential confounder. Unfortunately, our retrospectively analysed data were not suitable to answer this question because no patient in our study obtained an RI determination by two or more investigators at a certain time point. Therefore, we performed a small prospective study with 3 of the original 18 ultrasonographic investigators from our retrospective study. Fifteen renal transplant recipients were included and underwent an ultrasonographic RI determination by these investigators within 30 min. The degree of agreement among measurements was assessed by means of an intraclass correlation coefficient (ICC) and corresponding 95% limits of confidence (95% CI).
Results
In a ROC analysis, we evaluated the cut-off value for the RI. The highest sensitivity and specificity, as shown in Table 1 , were attained at three different RI values between 0.74 and 0.77 due to the three time periods. Therefore, we defined a cut-off value of the RI of 0.75 (Table 1) . Ranges and CIs for the RIs determined in the three defined time periods are shown in Supplementary table 1.
Baseline characteristics of the patients and their allografts stratified for the corresponding RI 12-18 months after transplantation are shown in Table 2 . Patients with an RI value >0.75, 12-18 months after transplantation, had a higher systolic blood pressure and a higher pulse pressure than patients with RI values of ≤0.75 (Table 2) .
Twenty patients (23%) reached the combined end point, on average, after 1888 days (SD 932). The determination of an RI value in both early time periods after transplantation [0-3 months, mean 10.8 (SD 7.9) days and 3-6 months, mean 121.6 (SD 26.8) days] was not predictive for renal allograft survival in the univariate Wald test (P = 0.21 and P = 0.22). In the earliest time period (0-3 months), 36 (41%) of the patients had an RI >0.75 and 12 of these patients (33%) reached the end point, whereas of the 52 patients (59%) with an RI value ≤0.75, 8 (15%) reached the end point. Three to six months after transplantation, 14 patients (16%) had an RI >0.75. Five of these patients (36%) reached the end point, whereas of the 74 patients with an RI value ≤0.75, 15 (20%) reached the end point.
However, the RI measured between 12 and 18 months [mean 427 (SD 48) days] revealed a significant predictive value for renal allograft failure or death in the univariate Wald test (P = 0.0013). Twelve (14%) of these patients had an RI >0.75 and 7 of these patients (58%) reached the end point, whereas of the 76 (86%) with an RI ≤0.75, only 13 (17%) reached the end point of terminal allograft failure or death.
Only 11 variables with a P-value <0.25 in the univariate analysis (Table 3) were included into the multivariate analysis. After a stepwise selection procedure, the RI measured between 12 and 18 months after transplantation showed the highest hazard ratio (HR 6.191, 95% CI 2.288-16.756, P = 0.0003) for the combined end point. Besides the RI measured between 12 and 18 months after transplantation, only the creatinine clearance at 2 years after transplantation [HR 0.973, 95% CI (0.948-0.998), P = 0.03] remains as significant influencing factor on transplant failure and/or death in the final model. At day of discharge from the hospital. Survival plots of time to the combined end point adjusted by means of creatinine clearance 2 years after transplantation were compared between the group with an RI of ≤0.75 and the group with an RI >0.75 measured between 12 and 18 months after transplantation (Figure 1) .
In the small prospective study regarding interobserver variability of RI determination in 15 transplant recipients, we obtained an ICC of 0.9114 (95% CI: 0.8080-0.9663) indicating a very strong agreement of measured RIs between the three different investigators.
Discussion
Our analysis confirms earlier findings [3] [4] [5] [6] [7] [8] of the power of the renal arterial RI in predicting renal allograft failure or death. Studies over the last decades found cut-off values for the RI ranging from 0.68 to 0.8 [3, 8, 9] . In our study, an RI >0.75, measured 12-18 months after transplantation, was the only significant predictor of the combined end point allograft failure or death in a multivariate model. Patients with an RI >0.75 were 6-fold more likely to experience allograft failure or death than patients with a lower RI. Furthermore, the calculated predictive values indicate that an RI below the cut-off can serve as a predictor of a favourable long-term outcome. All other clinical variables introduced in the multivariate model failed to be predictive for the long-term outcome.
Our major novel finding was that the RI measured within 6 months after transplantation does not predict allograft survival, whereas the RI measured between 12 and 18 months showed the highest discriminatory power of all variables. This is likely due to substantial intra-individual variability of the RI early after transplantation. These intra-individual fluctuations can be caused by the difficult ultrasound conditions directly after the operation, the newly developed anastomosis of the renal artery, the post- More than one renal transplantation-n (%) 1 (5) operative acute kidney injury and potential oedema of the allograft and the operative trauma in general. The renal RI is non-specific and is influenced by many factors, such as hypotension, bradycardia, manual compression by the transducer, haematoma, fluid collections, calcineurin inhibitor toxicity, pyelonephritis, acute tubular necrosis, glomerulonephritis, acute and chronic vascular rejection, renal vein thrombosis, delayed graft function and acute post-renal obstruction [10] . The literature of the last years has been inconsistent regarding the predictive power of RI measurements directly after transplantation for renal graft survival. The large trials of Radermacher and Loock with 601 and 425 patients did not include RI measurements performed earlier than 3 and 4 months, respectively, after transplantation [3, 11] . Kahraman et al. [4] found a correlation between the RI measured within the first week after transplantation and the level of renal function at 1 month and 1 year after transplantation. However, these investigators did not use the RI to predict allograft survival [4] . In contrast, Trillaud et al. [12] failed to confirm a relation between the RI measured within the first week after transplantation and the level of allograft function at 12 months. Saracino et al. [7] demonstrated, in a group of 76 kidney transplant patients, that the RI obtained within 1 month after transplantation is a predictive parameter for graft survival. However, in this study, the end point was a serum creatinine increase of >50% and neither death nor end-stage allograft failure. Finally, Akgul et al. [13] observed a significant predictive value for allograft survival with an RI <0.7, measured within 4 weeks after transplantation in a group of 121 patients. However, in this study, 84% of the patients received kidneys from a living donor. Kidney transplantation from a cadaveric donor is known to have a much longer cold ischaemia time, and donorrelated factors will also affect the ultrasonographic features of these kidneys. Therefore, the prognostic value of RIs measured shortly after transplantation could be different if the kidney is from a living or cadaveric donor.
Loock et al. [11] recently showed that a change in renal arterial RI ≥10% (ΔRI) between 4 months and 1 year after transplantation is a strong predictor of graft loss, whereas the absolute RI at both time points failed to be a significant predictor (RI cut-off ≥0.68). In our population, the ΔRI (both as a continuous variable and as a categorical variable ≥10 or ≥3% after ROC analysis) was not a significant predictor for allograft failure or death.
Since interobserver variability could be a confounding factor, we performed the small prospective study showing a very strong agreement of measured RIs between three different investigators. Therefore, in our opinion, interobserver variability is not relevant for RI determination.
Our study has several limitations. Given that we deliberately confined our assessment to three time periods, we could not determine a more exact time point after transplantation beyond which the measured RI becomes a significant predictor for renal allograft survival. We can only conclude that the time period during the first 6 months after transplantation is not suitable to be used to predict outcome. Radermacher et al. could show that urinary protein excretion >1 g/day is one of the strongest prediction parameters for renal allograft loss. Unfortunately, in our patient sample, we had no systematic data about urinary protein excretion. We included only 88 of 396 transplant recipients of our transplantation unit who underwent RI determinations in three predefined time periods after transplantation. We cannot exclude that this might have introduced selection bias, as transplant patients with special clinical problems that need more frequent Doppler examinations had a higher chance to be included. Therefore, strictly speaking, our conclusion of limited predictive power of RI measurements 0-3 and 3-6 months after transplantation only holds true for a transplant recipient population with medical conditions comparable to the present cohort. In consequence, our results are not transferable to patients whose very stable conditions allowed follow-up visits outside the University Hospital or less intense schedules for duplex sonography in one or two of the specified time points.
In conclusion, we propose the measurement of renal arterial RI as a powerful predictor of renal allograft failure or death. However, the present data expand previous findings. Our study is the first to suggest that the time point of RI measurement after transplantation affects its utility as a prognostic parameter. In our subpopulation of 88 transplant recipients, RIs obtained within the first 6 months after transplantation were not predictive, whereas the RIs measured 12-18 months after transplantation were significant predictors for long-term allograft outcomes and death.
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